US FDA approves Novo Nordisk’s Ozempic 2 mg to treat type-II diabetes EP News Bureau Mar 30, 2022 Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose
Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData EP News Bureau May 19, 2021 The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to…
T2D market will grow from a total of $48.1bn sales in 2019 to $91.9 bn in 2029 EP News Bureau Nov 17, 2020 T2D market growth factors are increasing diagnosed prevalence of disease and the emergence of novel pipeline agents
